XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Treasury [Member]
Additional Paid In Capital [Member]
Retained Earnings [Member]
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (877,000)    
Common stock, shares, outstanding at Dec. 31, 2019   80,079,000      
Beginning Balance, value at Dec. 31, 2019 $ 104,076 $ 8,008 $ (5,090) $ 553,210 $ (452,052)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net loss (69,104)       (69,104)
Purchase of treasury stock, shares     (165,000)    
Purchase of treasury stock, value (7)   $ (7)    
Equity awards vested or exercised, shares   542,000      
Equity awards vested, issued, or exercised, value   $ (54)   54  
Stock-based compensation expense 328     328  
Common stock, shares, outstanding at Mar. 31, 2020   80,621,000      
Ending Balance, value at Mar. 31, 2020 $ 35,293 $ 8,062 $ (5,097) 553,484 (521,156)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (1,042,000)    
Treasury Stock, Shares     (1,000)    
Common stock, shares, outstanding at Dec. 31, 2020 1,647,224 1,649,000      
Beginning Balance, value at Dec. 31, 2020 $ 101,897 $ 2 $ 0 142,119 (40,224)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net loss (16,942)       (16,942)
Stock-based compensation expense $ 830     830  
Common stock, shares, outstanding at Mar. 31, 2021 1,647,224 1,649,000      
Ending Balance, value at Mar. 31, 2021 $ 85,785 $ 2 $ 0 $ 142,949 $ (57,166)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (1,000)